All In MedTech

Device Trial Radar · NCT01368744

Clinical Evaluation of OSNA Breast Cancer System to Extensive Frozen Section Histopathology

Intraoperative Examination of Sentinel Lymph Nodes: Comparison of the OSNA Breast Cancer System to Extensive Frozen Section Histopathology

Last checked: Nov 19, 2026Latest source record: Jun 8, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

150

Planned (sponsor's estimate)

Start

Mar 2010

Primary completion

Jun 2011

Study completion Jun 2011

Sponsor

Lead sponsor
Sysmex America, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jun 8, 2011

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study will determine the sensitivity, specificity, negative predictive value and positive predictive value of the OSNA Breast Cancer System by comparing its performance to an extensive intraoperative frozen section protocol for Sentinel Lymph Nodes removed during standard Sentinel Lymph Node biopsy procedures from breast cancer subjects.

Conditions

  • Breast Neoplasms
  • Breast Diseases

Interventions

  • OSNA Breast Cancer SystemDevice

    For in vitro diagnostic use only. The OSNA Breast Cancer System is an automated semi-quantitative, in vitro diagnostic test for the rapid detection of greater than (\>) 0.2 mm metastases in nodal tissue removed from sentinel lymph node biopsies of breast cancer patients. Results from the assay can be used to guide the intra-operative or post-operative decision to remove additional lymph nodes and to aid in patient staging. An assay positive + or ++ result indicates the presence of metastasis (\> 0.2 mm). An assay positive ++ result predicts the presence of macrometastasis (\> 2 mm). Groups: OSNA Breast Cancer System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Prospectively assess the concordance and performance of the OSNA Breast Cancer System with an extensive intraoperative frozen section protocol for SLNs removed using standard SLN biopsy procedures from breast cancer subjects.Time frame: 3 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Milan School of Medicine

    Milan, Italy, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.